Life Sciences & Biotechnology, Pharmaceutical Sciences, COVID-19 Technology
Title: | Process Development of Drugs Repurposed for COVID-19 |
Area: | Life Sciences & Biotechnology, Pharmaceutical Sciences, COVID-19 Technology |
Focus Area: | Development of Repurposed Drugs for COVID-19 |
Developing Agency: | National Institute for Interdisciplinary Science and Technology (CSIR-NIIST), Thiruvananthapuram |
Technology Readiness Index: | Technology development |
| Website Link : | https://www.niist.res.in/english/ |
Brief Description
Description : | Process developed for Nitazoxanide, EIDD 1931 & EIDD 2801. Non-infringing routes developed for the APIs. Nitazoxanide is currently under clinical trials in Mexico. EIDD 2801 is currently under clinical trials in USA & UK. |
Related Technologies